e-learning
resources
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis
Gilchrist Francis J., Belcher John, Jones Andrew M., Smith David, Smyth Alan R., Southern Kevin W., Špan?l Patrik, Webb A. Kevin, Lenney Warren
Source:
ERJ Open Res 2015; 1: 00044-2015
Journal Issue:
December
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Gilchrist Francis J., Belcher John, Jones Andrew M., Smith David, Smyth Alan R., Southern Kevin W., Špan?l Patrik, Webb A. Kevin, Lenney Warren. Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis. ERJ Open Res 2015; 1: 00044-2015
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Detection of Pseudomonas aeruginosa in exhaled breath of cystic fibrosis patients
Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments
Year: 2018
Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020
The sensitivity and specificity of
pseudomonas aeruginosa
detection using hydrogen cyanide concentration in exhaled breath – The SPACE study
Source: International Congress 2014 – Cystic fibrosis: assessment and treatment
Year: 2014
Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis
Source: Eur Respir J 2011; 37: 553-558
Year: 2011
Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis
Source: Eur Respir J 2007; 30: 286-292
Year: 2007
Does sputum induction improve
Pseudomonas aeruginosa
detection in cystic fibrosis?
Source: Eur Respir J 2003; 22: Suppl. 45, 231s
Year: 2003
Bacterial cyanogenesis occurs in the cystic fibrosis lung
Source: Eur Respir J 2008; 32: 329-333
Year: 2008
Exhaled pentane – a new breath test in cystic fibrosis?
Source: Annual Congress 2006 - New developments in infant and intensive care lung function
Year: 2006
Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients
Source: Eur Respir J 2008; 32: 740-747
Year: 2008
Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 468s
Year: 2004
Nitric oxide metabolites (NOx) in exhaled breath condensate as a non-invasive marker of airway inflammation in infants with cystic fibrosis. Comparisons with bronchoalveolar lavage findings
Source: Eur Respir J 2004; 24: Suppl. 48, 157s
Year: 2004
Exhaled hydrogen sulfide in patients with chronic airway inflammatory disease
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis
Source: Eur Respir J 2013; 42: 1723-1736
Year: 2013
Increased IL-8 in exhaled breath condensate in cystic fibrosis during acute exacerbation
Source: Eur Respir J 2001; 18: Suppl. 33, 537s
Year: 2001
Correlation analysis of the colonization by
Pseudomonas aeruginosa
and genetic polymorphism of nitric oxide synthases in patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 727s
Year: 2005
Exhaled breath temperature in adult cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Year: 2011
Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis
Source: Eur Respir J 2004; 24 : 631-637
Year: 2004
Chronic but not intermittent infection with
Pseudomonas aeruginosa
is associated with global changes of the lung microbiome in cystic fibrosis
Source: Eur Respir J, 50 (4) 1701086; 10.1183/13993003.01086-2017
Year: 2017
Breath condensate is acidified during infective exacerbations in children with cystic fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 527s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept